Rheumatism and COVID-19 repository

The EULAR guidance for patients and an array of useful resources about the current COVID-19 outbreak to give our patients with Rheumatic Musculoskeletal Diseases (RMDs) the best possible care. 

 

EULAR Reporting database

• EULAR - COVID-19 Reporting database for rheumatologists and other clinicians

 

EULAR Guidance

• EULAR Guidance for patients with RMDs about COVID-19 outbreak

 

Other guidance

Different Recommendations have been made worldwide for patients suffering from Rheumatic Musculoskeletal Diseases; this one is made by our French colleagues and will be updated soon.

• FAI²R: How to live better during this containment period
• FAI²R: Recommendations for patients suffering from RMDs

 

EULAR Recommended read

• EULAR calls on governments in Europe to recognise the most vulnerable during COVID-19

 

External resources

Organisations & agencies

• American College of Rheumatology: ACR’s FAQ page on COVID-19
• Centers for Disease Control and Prevention (CDC): Coronavirus (COVID-19) 
• COVID-19 Global Rheumatology Alliance
• European Centre for Disease Prevention and Control (ECDC): Coronavirus disease
• European Commission: The coronavirus response team
• European Medicines Agency (EMA): EMA gives advice on the use of non-steroidal anti-inflammatories for COVID-19
• European Medicines Agency (EMA): Coronavirus disease (COVID-19)
• Robert Koch Institute Germany: SARS-CoV-2 in Germany
• World Health Organization (WHO): Coronavirus disease (COVID-19) outbreak

National societies

• British Society for Rheumatology (BSR): Covid-19 (Coronavirus) - update for members 
• National Axial Spondyloarthritis Society United Kingdom: Advice on COVID19 / Coronavirus 
• National Rheumatoid Arthitis Society (NRAS): Coronavirus: What we know so far 

Other

• National Center for Biotechnology Information, U.S. National Library of Medicine: Results of research conducted in the Computational Biology Branch, NCBI/NLM, on COVID-19
• UpToDate Inc: Coronavirus disease 2019 (COVID-19)